eClinical Technology and Industy News

Elucida Oncology Announces Three Key Additions to Its Board of Directors and the Appointment of Robert Essner as Chairman of the Board

Excerpt from the Press Release:

MONMOUTH JUNCTION, N.J., April 29, 2021 (GLOBE NEWSWIRE) — Elucida Oncology, a biotechnology company pioneering the next frontier in targeted cancer therapy, announced today three key additions to its Board of Directors: Dr. David Zaccardelli, Ms. Natalie McDonald, and Mr. Gary Sender. The company also announced the transition of Robert Essner from Executive Chairman to Chairman of the Board.

“As our company has grown and matured, we have looked to expand the experience and capabilities of the Board, and we are thrilled to have attracted three proven industry leaders. Their vast and diverse experiences will help enormously in guiding the further development of our unique platform and help us reach our goals for improving the care of cancer patients,” stated Geno Germano, President and CEO of Elucida Oncology.

Dr. Zaccardelli has been President and CEO of Verona Pharma since February 2020. Previously, he served as President and CEO of Dova Pharmaceuticals from December 2018 until its acquisition by Sobi in November 2019. Dr. Zaccardelli was the Acting CEO of Cempra, Inc. from December 2016 until the company’s merger with Melinta Therapeutics, Inc., in November 2017. From 2004 until 2016, Dr. Zaccardelli served in several senior management roles at United Therapeutics Corporation, including COO, Chief Manufacturing Officer and Executive Vice President, Pharmaceutical Development and Operations. Prior to joining United Therapeutics, he held various positions at Burroughs Wellcome & Co. and Bausch & Lomb Pharmaceuticals. Dr. Zaccardelli received a Pharm.D. from the University of Michigan.

Click the button below to read the entire Press Release:

Continue Reading The Press Release

Discover What Sets TrialStat Apart From Ordinary EDC Platforms

Click the image or button below to explore our eClinical Suite Platform and discover what sets TrialStat apart from competing EDC platforms.

Request Your Demo Today!

From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?